
The Library Media — Business & Markets · Markets Desk
Australia Markets — Mid-Morning Update: ASX 200 Extends Losses as Mayne Pharma Soars on Takeover (Nov 17, 2026)
By Clara Ledger
Photo: Mikecligon / Wikimedia Commons (CC0)
The S&P/ASX 200 fell to 8,903.20 by 12:00:45 PM AEDT on Tuesday, down 141.50 points, or 1.56% (Yahoo Finance, Nov 17, 2026). The index opened at Monday’s close of 9,044.70 and moved lower through the morning, reaching 8,903.20 after trading between 8,902.10 and 9,044.70. The decline deepened rather than stabilised after the previous session’s losses, with miners and banks again among the weaker groups.
Biggest gainers
Mayne Pharma Group Limited (MYX) +87.07% 6.01 AUD — Hungarian drugmaker Gedeon Richter agreed to acquire Mayne Pharma for A$6.40 cash per share, valuing the equity at about A$604 million, under a scheme implementation agreement announced Tuesday (Reuters/Australian Financial Review/Motley Fool Australia, Nov 17).
Imagion Biosystems Limited (IBX) +50.00% 0.0060 AUD — No confirmed driver reported for this move.
Lithium Universe Limited (LU7) +33.33% 0.0020 AUD — No confirmed driver reported for this move.
Biggest losers
Enova Mining Limited (ENV) -33.33% 0.0010 AUD — No confirmed driver reported for this move.
Terrain Minerals Limited (TMX) -33.33% 0.0020 AUD — No confirmed driver reported for this move.
Aruma Resources Limited (AAJ) -25.00% 0.0030 AUD — No confirmed driver reported for this move.
The broader market pressure continued after U.S. equities fell on Monday, with the S&P 500 down 1.92%, the Nasdaq Composite off 2.49%, Nvidia lower by 3.98%, and Intel down 9.54%, according to Yahoo Finance. The global chip selloff followed Jensen Huang’s Nov 11 resignation. In Australia, miners and banks extended their declines during Tuesday morning trading: BHP fell 3.57%, Rio Tinto lost 1.95%, Fortescue declined 2.84%, and Mineral Resources dropped 6.00%. NAB fell 2.42% and Macquarie Group lost 3.02%. The RBA remains in focus, as noted in the pre-market briefing.
This update differs from the pre-market picture in one important respect: the ASX 200 did not stabilise at Monday’s close but fell steadily after opening there. Mayne Pharma was the standout exception, surging after Gedeon Richter’s A$6.40-per-share cash takeover agreement. The three current-session gainers and losers above are the Tuesday mid-morning movers; stale or Monday-only quotes have been excluded. The figures are StockAnalysis observations at the times supplied, not a complete end-of-day ranking.
Clara Ledger
Markets Desk, The Library Media
From The Library — the estate of our family.
Follow Us
